Search Within

Kenneth Ho-Ming Yu

  1. "Body Imaging Service"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (7)
Groups
  1. Body Imaging Service (17)
  2. Center for Pancreatic Cancer Research (17)
  3. Department of Medicine (17)
  4. Gastrointestinal Oncology Service (17)
  5. Radiology, Department of (17)
  6. Solid Tumor Oncology Division (17)

More Groups

People
  1. Eileen O'Reilly (16)
  2. Kinh Gian Do (14)
  3. Maeve Lowery (12)
  4. Marinela Capanu (10)
  5. David Kelsen (9)
  6. Zsofia Stadler (7)

More People

Years
  1. 2021 (1)
  2. 2020 (2)
  3. 2018 (6)
  4. 2017 (2)
  5. 2016 (1)
  6. 2015 (1)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Annals of Oncology (1)
  3. British Journal of Cancer (1)
  4. Cancer (1)
  5. Cancers (1)
  6. Clinical Colorectal Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. Elsevier Inc. (2)
  3. Karger (1)
  4. MDPI (1)
  5. Nature Publishing Group (1)
  6. Oxford University Press (1)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical impact of visceral thrombosis (VT) in pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Hicks, A. M.; Raj, M.; Do, R. K. G.; Yu, K. H.; Lowery, M. A.; Varghese, A. M.; O'Reilly, E. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase 1B trial of ADI-PEG 20 (A) plus nab-paclitaxel (nab-P) and gemcitabine (gem) in subjects with advanced pancreatic cancer (APC)
    Meeting Abstract

    Lowery, M. A.; Capanu, M.; Glassman, D. C.; Covington, C. M.; Gluskin, J.; Brenner, R.; Li, C. F.; Bomalaski, J. S.; Johnston, A.; Barba, A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase II trial of veliparib (V) in patients (pts) with previously treated BRCA or PALB2-mutated (mut) pancreas adenocarcinoma (PC)
    Meeting Abstract

    Lowery, M. A.; Kelsen, D. P.; Smith, S. C.; Moore, M.; Kindler, H. L.; Golan, T.; Segal, A.; Hollywood, E.; Maynard, H.; Capanu, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Segal, M. F.; Smith, S. C.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; Salo-Mullen, E. E.; Hollywood, E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression
    Journal Article

    Li, D.; Pant, S.; Ryan, D. P.; Laheru, D.; Bahary, N.; Dragovich, T.; Hosein, P. J.; Rolfe, L.; Saif, M. W.; Lavalle, J.; more...
    Pancreatology (2014)

    Fulltext@MSK | Save
  • Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V) (arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in patients with BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; Capanu, M.; Stadler, Z. K.; Epstein, A. S.; Golan, T.; Segal, A.; Segal, M.; Salo-Mullen, E. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas
    Journal Article

    Lee, J. K.; Capanu, M.; O'Reilly, E. M.; Ma, J.; Chou, J. F.; Shia, J.; Katz, S. S.; Gansukh, B.; Reidy-Lagunes, D.; Segal, N. H.; more...
    British Journal of Cancer (2013)

    Fulltext@MSK | Save